Baseimmune

Baseimmune is a computational biotechnology company pioneering the next generation of active immunotherapies by combining cutting-edge computational design with advanced protein engineering. Founded in 2019 by Joshua Blight and Ariane Gomes — who met during their PhDs at the Jenner Institute, University of Oxford — the company has developed an AI-driven vaccine design platform that integrates genomic, epidemiological, immunological, clinical, and evolutionary data to create synthetic antigens for vaccines. The platform creates bespoke antigens that address the complexity of chronic diseases, unlocking new therapeutic possibilities where traditional vaccine development approaches fall short. Baseimmune is headquartered in London and has raised over $11M in funding from investors including Hoxton Ventures and IQ Capital.